Since the establishment in 2016, MEGAROBO has been devoting in becoming an intelligent automation expert in life sciences, clinical diagnostics, applied chemistry, advanced manufacturing and more fields, enabling breakthrough innovation of industry and productivity to create a more efficient, healthier and better world.

MEGAROBO is focusing on robotics and AI technology R&D applied in industrial scenarios, where we provide intelligent automation products and total solutions to our partners. With MEGALAB, an automated intelligent life sciences lab developed by MEGAROBO, we enable automation transformation in drug discovery and development, cell and gene therapy, organoid development, and synthetic biology.

Additionally, MEGAROBO is a leading innovator in the semiconductor manufacturing and testing equipment industry, providing numerous mature products and solutions to top industry players.

MEGAROBO has assembled a talent and interdisciplinary team including close to 100 scientists with PhD degrees and 500 experienced engineers and has filed over 350 patents. MEGAROBO is headquartered in Suzhou, China, with local branches in Beijing, Shanghai, and Shenzhen. And overseas headquarters is located in Singapore, with R&D centers in the United States, the United Kingdom and Japan.

MEGAROBO has closed the Series C financing. We have been favoured and recognized by many top strategic and institutional investors, such as WuXi AppTec, Bosch, Goldman Sachs Asset Management, Asia Investment Capital, GGV Capital, Sinovation Ventures, Joy Capital, and Matrix Partners China, Pavilion Capital.